王志桐, 王晓良. 线粒体阴离子通道VDAC1作为阿尔茨海默病潜在药物靶标的研究进展J. 药学学报, 2018,53(8): 1250-1258. doi: 10.16438/j.0513-4870.2018-0289
引用本文: 王志桐, 王晓良. 线粒体阴离子通道VDAC1作为阿尔茨海默病潜在药物靶标的研究进展J. 药学学报, 2018,53(8): 1250-1258. doi: 10.16438/j.0513-4870.2018-0289
WANG Zhi-tong, WANG Xiao-liang. Research progress of mitochondrial anion channel as a potential drug target for Alzheimer's diseaseJ. Acta Pharmaceutica Sinica, 2018,53(8): 1250-1258. doi: 10.16438/j.0513-4870.2018-0289
Citation: WANG Zhi-tong, WANG Xiao-liang. Research progress of mitochondrial anion channel as a potential drug target for Alzheimer's diseaseJ. Acta Pharmaceutica Sinica, 2018,53(8): 1250-1258. doi: 10.16438/j.0513-4870.2018-0289

线粒体阴离子通道VDAC1作为阿尔茨海默病潜在药物靶标的研究进展

Research progress of mitochondrial anion channel as a potential drug target for Alzheimer's disease

  • 摘要: 电压依赖性阴离子通道(voltage-dependent anion channels,VDACs)位于线粒体外膜,在调节线粒体能量代谢和线粒体介导细胞凋亡中起着关键作用,被认为是肿瘤治疗的潜在靶点。研究表明,阿尔茨海默病(Alzheimer's disease,AD)等神经退行性疾病普遍会导致线粒体功能障碍。在此过程中,VDAC1表达发生改变,并与疾病相关分子存在相互作用,参与了疾病的发生、发展过程。本综述阐述了VDAC1的特征、生理功能,目前报道较多的重要结构单元及其在细胞凋亡中的作用,着重介绍了VDAC1在AD中的研究进展,以及调节VDAC1表达或功能对学习记忆相关功能的影响。

     

    Abstract: Voltage-dependent anion channels (VDACs), which are located at the mitochondrial outer membrane, playing an important role in the regulation of mitochondrial energy metabolism and mitochondria- mediated apoptotic events, are considered as potential targets for tumor therapy. Studies have indicated that neurodegenerative diseases such as Alzheimer's disease (AD) generally lead to mitochondrial dysfunction. During this process, VDAC1, changing in expression, interacting with disease-related molecules, was involved in the occurrence and development of diseases. This review summarizes the characteristics and physiological functions of VDAC1, common important structural units and its role in apoptosis. The focus is on the research progress of VDAC1 in AD, as well as the effects in learning and memory related functions by modulating VDAC1 expression or function.

     

/

返回文章
返回